Publication | Closed Access

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Rheumatoid DisorderRheumatologyAutoimmune DiseaseAllergyPhase 4Rheumatic DiseasesClinical TrialsInflammatory Rheumatic DiseaseImmunotherapyMedicineRheumatoid Arthritis